AI Science Tracker
EN

Nanjing Drum Tower Hospital

1 discovery from 2026

Discoveries

Mucosal and cellular immune measures predicted SARS-CoV-2 reinfection

Source check: Source checked. Not independent scientific confirmation.

Finding: Across two community cohorts followed for a median 10 months, 1,156 participants had 128 observed reinfections. An interpretable XGBoost model identified nasal spike-specific IgA and spike-specific CD4+ central-memory T cells as informative predictors of subsequent reinfection. Predictive associations do not establish that the immune measures causally prevent reinfection or imply clinical benefit; the reviewed evidence does not establish testing of a frozen model before new outcomes.

Technology: Interpretable XGBoost

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
XGBoost integrated mucosal antibody and cellular immune measurements to predict observed reinfection.
Test and result
Across two community cohorts followed for a median 10 months, 1,156 participants had 128 observed reinfections. An interpretable XGBoost model identified nasal spike-specific IgA and spike-specific CD4+ central-memory T cells as informative predictors of subsequent reinfection.
Limitation / still unknown
Predictive associations do not establish that the immune measures causally prevent reinfection or imply clinical benefit; the reviewed evidence does not establish testing of a frozen model before new outcomes.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://europepmc.org/articles/PMC13700530

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Original full-text Methods and Results reviewed from the primary paper or preprint; first result-bearing version checked from the supplied source review; author affiliations checked against exact-DOI metadata where available..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.